Quanterix Corp
NASDAQ:QTRX
Quanterix Corp
NASDAQ:QTRX
Price:
16.51 USD
-4.9%
Market Closed
Updated:
May 9, 2024
Section:
Relative Value
The Relative Value of one
QTRX
stock under the Base Case scenario is
24.5
USD.
Compared to the current market price of 16.51 USD,
Quanterix Corp
is
Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QTRX
Relative Value
Base Case
24.5
USD
Undervaluation 33%
Valuation Multiples
Multiples Across Competitors
QTRX Competitors Multiples
Quanterix Corp Competitors
Quanterix Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Quanterix Corp
NASDAQ:QTRX
|
627.6m USD | 5.1 | -19.4 | -7.3 | -6.4 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.9B USD | 5.2 | 37 | 22.9 | 33.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
184.1B USD | 4.2 | 22.9 | 16.6 | 20.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
41.7B USD | 6.2 | 33.9 | 26.9 | 32.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.7B CHF | 5.7 | 58 | 19.8 | 29.1 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
56.3T KRW | 15.2 | 65.6 | 34.6 | 49.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.3B USD | 2.8 | 30.5 | 16.6 | 25.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.1B USD | 7.1 | 34.2 | 24 | 26.7 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 47.1 | 32.5 | 39.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.8B USD | 3.1 | 37.7 | 17 | 26.2 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
18.8B EUR | 6.9 | 74 | 31.9 | 52.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
